Cargando…

Comprehensive Deep Mutational Scanning Reveals the Immune-Escaping Hotspots of SARS-CoV-2 Receptor-Binding Domain Targeting Neutralizing Antibodies

The rapid spread of SARS-CoV-2 has caused the COVID-19 pandemic, resulting in the collapse of medical care systems and economic depression worldwide. To combat COVID-19, neutralizing antibodies have been investigated and developed. However, the evolutions (mutations) of the receptor-binding domain (...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tsai, Keng-Chang, Lee, Yu-Ching, Tseng, Tien-Sheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8319916/ https://www.ncbi.nlm.nih.gov/pubmed/34335530 http://dx.doi.org/10.3389/fmicb.2021.698365

Ejemplares similares

Antigen–Antibody Complex-Guided Exploration of the Hotspots Conferring the Immune-Escaping Ability of the SARS-CoV-2 RBD
por: Fung, Kit-Man, et al.
Publicado: (2022)

A Combination of Receptor-Binding Domain and N-Terminal Domain Neutralizing Antibodies Limits the Generation of SARS-CoV-2 Spike Neutralization-Escape Mutants
por: Haslwanter, Denise, et al.
Publicado: (2021)

Deep mutational scans for ACE2 binding, RBD expression, and antibody escape in the SARS-CoV-2 Omicron BA.1 and BA.2 receptor-binding domains
por: Starr, Tyler N., et al.
Publicado: (2022)

Preventing escape from neutralizing antibodies
por: Brown, Matthew
Publicado: (2020)

A Bacterially Expressed SARS-CoV-2 Receptor Binding Domain Fused With Cross-Reacting Material 197 A-Domain Elicits High Level of Neutralizing Antibodies in Mice
por: Liu, Liqin, et al.
Publicado: (2022)

Comprehensive mapping of binding hot spots of SARS-CoV-2 RBD-specific neutralizing antibodies for tracking immune escape variants
por: Yi, Chunyan, et al.
Publicado: (2021)

Substitution at Aspartic Acid 1128 in the SARS Coronavirus Spike Glycoprotein Mediates Escape from a S2 Domain-Targeting Neutralizing Monoclonal Antibody
por: Ng, Oi-Wing, et al.
Publicado: (2014)

Comprehensive engineering of a therapeutic neutralizing antibody targeting SARS-CoV-2 spike protein to neutralize escape variants
por: Kuramochi, Taichi, et al.
Publicado: (2022)

Two Escape Mechanisms of Influenza A Virus to a Broadly Neutralizing Stalk-Binding Antibody
por: Chai, Ning, et al.
Publicado: (2016)

Complete mapping of viral escape from neutralizing antibodies
por: Doud, Michael B., et al.
Publicado: (2017)

Delta-Omicron recombinant escapes therapeutic antibody neutralization
por: Duerr, Ralf, et al.
Publicado: (2023)

Deep mutational learning predicts ACE2 binding and antibody escape to combinatorial mutations in the SARS-CoV-2 receptor-binding domain
por: Taft, Joseph M., et al.
Publicado: (2022)

An antibody-escape calculator for mutations to the SARS-CoV-2 receptor-binding domain
por: Greaney, Allison J., et al.
Publicado: (2021)

An antibody-escape estimator for mutations to the SARS-CoV-2 receptor-binding domain
por: Greaney, Allison J, et al.
Publicado: (2022)

Exploring the mode of action of inhibitors targeting the PhoP response regulator of Salmonella enterica through comprehensive pharmacophore approaches
por: Tsai, Keng-Chang, et al.
Publicado: (2019)

Antibody Isotype Switching as a Mechanism to Counter HIV Neutralization Escape
por: Scheepers, Cathrine, et al.
Publicado: (2020)

Deep Structural Analysis of Myriads of Omicron Sub-Variants Revealed Hotspot for Vaccine Escape Immunity
por: Gerardi, Valeria, et al.
Publicado: (2023)

Wastewater treatment plants, an “escape gate” for ESCAPE pathogens
por: Marutescu, Luminita Gabriela, et al.
Publicado: (2023)

Structural Basis of HCV Neutralization by Human Monoclonal Antibodies Resistant to Viral Neutralization Escape
por: Krey, Thomas, et al.
Publicado: (2013)

A Class of Shark‐Derived Single‐Domain Antibodies can Broadly Neutralize SARS‐Related Coronaviruses and the Structural Basis of Neutralization and Omicron Escape
por: Feng, Bo, et al.
Publicado: (2022)

Decoding the effects of spike receptor binding domain mutations on antibody escape abilities of omicron variants
por: Chakraborty, Sandipan, et al.
Publicado: (2022)

Pichia pastoris-Expressed Bivalent Virus-Like Particulate Vaccine Induces Domain III-Focused Bivalent Neutralizing Antibodies without Antibody-Dependent Enhancement in Vivo
por: Shukla, Rahul, et al.
Publicado: (2018)

Engineering the Single Domain Antibodies Targeting Receptor Binding Motifs Within the Domain III of West Nile Virus Envelope Glycoprotein
por: Hruškovicová, Jana, et al.
Publicado: (2022)

Antibody-Dependent Cellular Cytotoxicity (ADCC)-Mediating Antibodies Constrain Neutralizing Antibody Escape Pathway
por: Mielke, Dieter, et al.
Publicado: (2019)

Functional epitopes and neutralizing antibodies of vaccinia virus
por: Peng, Fenghao, et al.
Publicado: (2023)

Antibodies to the SARS-CoV-2 receptor-binding domain that maximize breadth and resistance to viral escape
por: Starr, Tyler N., et al.
Publicado: (2021)

Limited Neutralizing Antibody Specificities Drive Neutralization Escape in Early HIV-1 Subtype C Infection
por: Moore, Penny L., et al.
Publicado: (2009)

Recognition of the SARS-CoV-2 receptor binding domain by neutralizing antibodies
por: Yuan, Meng, et al.
Publicado: (2021)

Mutational Hotspot in the SARS-CoV-2 Spike Protein N-Terminal Domain Conferring Immune Escape Potential
por: Kubik, Slawomir, et al.
Publicado: (2021)

Immunodominant antibody responses directed to SARS-CoV-2 hotspot mutation sites and risk of immune escape
por: Oliveira, Jamille Ramos, et al.
Publicado: (2023)

Development of Neutralizing and Non-neutralizing Antibodies Targeting Known and Novel Epitopes of TcdB of Clostridioides difficile
por: Fühner, Viola, et al.
Publicado: (2018)

Complementary recognition of the receptor-binding site of highly pathogenic H5N1 influenza viruses by two human neutralizing antibodies
Publicado: (2018)

Escape From Monoclonal Antibody Neutralization Affects Henipavirus Fitness In Vitro and In Vivo
por: Borisevich, Viktoriya, et al.
Publicado: (2016)

Norovirus Escape from Broadly Neutralizing Antibodies Is Limited to Allostery-Like Mechanisms
por: Kolawole, Abimbola O., et al.
Publicado: (2017)

Development of AAV Variants with Human Hepatocyte Tropism and Neutralizing Antibody Escape Capacity
por: Pei, Xiaolei, et al.
Publicado: (2020)

Restriction of HIV-1 Escape by a Highly Broad and Potent Neutralizing Antibody
por: Schommers, Philipp, et al.
Publicado: (2020)

Mechanisms of Hepatitis C Virus Escape from Vaccine-Relevant Neutralizing Antibodies
por: Velázquez-Moctezuma, Rodrigo, et al.
Publicado: (2021)

Searching for escape-resistant anti–SARS-CoV-2 neutralizing antibodies
por: Mahla, Ranjeet Singh, et al.
Publicado: (2022)

Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies
por: Cao, Yunlong, et al.
Publicado: (2021)

Pichia pastoris-expressed dengue 3 envelope-based virus-like particles elicit predominantly domain III-focused high titer neutralizing antibodies
por: Tripathi, Lav, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_0mh5jpcekslf0kbban9veqc3u8